Monday, June 1, 2015
Astrazeneca Presents Positive Data On Azd9291 In First-Line Egfr Mutated Lung Cancer
… EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Results from a phase … histological samples in non-small cell lung cancer: a Polish, single institution study … with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment